Tetrahydrocannabivarin for use in the treatment of nausea and vomiting
US9675579B2 · kind B2 · utility
25Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 14, 2014 |
| Grant date | Jun 13, 2017 |
| Priority date | — |
| Expiry date | Apr 14, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of tetrahydrocannabivarin (THCV) in the treatment of nausea and vomiting. Preferably the THCV is isolated and/or purified from cannabis plant extracts. Preferably the nausea and/or vomiting is caused by the effects of a medication such as a chemotherapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.